Page 1

Eligibility CriteriaCreated Monday, November 17, 2014

Page 1

Please review each eligibility criteria below. Please check the box if you are in compliance witheach criteria.

Ineligible applicants will not be reviewed.

•  Nominee is a clinical science investigator at the Assistant Professor level within the first seven (7) years of initial appointment asan Assistant Professor.

•  Nominee must show contributions to the field of transplant medicine since gaining independence and must show promise ofcontinued contributions to the field

•  Nominee and nominator are active members of the AST. Membership dues must be paid to date (by 1/1/2015); otherwise thenomination will be disqualified and not considered.

Page 1

Personal Information FormCreated Monday, November 17, 2014

Personal Information

Nominee Information

Please enter in all information for nominee.

Nominee Information | First Name David

Nominee Information | Last Name Goldberg

Nominee Information | Degree MD, MSCE

Nominee Information | Title Instructor A in Medicine

Nominee Information | Institution University of Pennsylvania

Nominee Information | Department Division of Gastroenterology

Nominee Information | Address Blockley Hall, 423 Guardian DriveRoom 730

Nominee Information | City Philadelphia

Nominee Information | State/Province Pennsylvania

Nominee Information | Zip/Postal Code 19104

Nominee Information | Country United States

Nominee Information | Phone number 215-349-8222

Nominee Information | Email david.goldberg@uphs.upenn.edu

Nominator Information

Please enter in all information for nominator.

Nominator Information | First Name Susan

Nominator Information | Last Name Orloff

Nominator Information | Degree MD

Nominator Information | Title Chief, Division of Abdominal Organ Transplantation/Hepatobiliary Surgery

Nominator Information | Institution Oregon Health & Science University

Nominator Information | Department Division of Abdominal Organ Transplantation/Hepatobiliary Surgery

Nominator Information | Address 3181 S.W. Sam Jackson Park RoadMC: L590

Nominator Information | City Portland

Nominator Information | State/Province Oregon

Nominator Information | Zip/Postal Code 97239

Nominator Information | Country United States

Nominator Information | Phone number 503-494-7810

Nominator Information | Email orloffs@ohsu.edu

Page 2

Is this nomination made on behalf of an AST advisory council, committee, or community ofpractice?

Yes

If yes, please list advisory council/committee/community of practice name:

Liver & Intestinal COP

UNIVERSITY OF PENNSYLVANIA - PERELMAN SCHOOL OF MEDICINECurriculum Vitae

Date: 11/4/2014

David Seth Goldberg, MD, MSCE

David Seth Goldberg, MD, MSCEPage ,

Address: Division of Gastroenterology

Blockley Hall, 423 Guardian Drive Room 730 Philadelphia, PA 19104 United States

Education:2001 BA Brown University (Judaic Studies)2005 MD Mount Sinai School of Medicine2011 MSCE University of Pennsylvania

Postgraduate Training and Fellowship Appointments:2005-2006 Intern in Internal Medicine, New York Presbyterian Hospital-

Columbia University Medical Center2006-2008 Resident in Internal Medicine, New York Presbyterian

Hospital-Columbia University Medical Center2008-2011 Fellow in Gastroenterology, Hospital of the University of

Pennsylvania2012-2013 Fellow in Transplant Hepatology, Hospital of the University of

Pennsylvania

Faculty Appointments:2011-2013 Instructor B in Medicine, Department of Medicine, Hospital of

the University of Pennsylvania 2013-present Instructor A in Medicine, Department of Medicine, University

of Pennsylvania Perelman School of Medicine

Hospital and/or Administrative Appointments:2013-present Medical Director for Living Donor Liver Transplantation,

Hospital of the University of Pennsylvania

Other Appointments:2011-2014 Faculty Fellow, Center for Clinical Epidemiology and

Biostatistics2012-present Investigator-in-Training, Center for Pharmacoepidemiology

Research and Training, University of Pennsylvania2013-present LDI Fellow, Leonard Davis Institute, University of

Pennsylvania2014-present Senior Scholar, Center for Clinical Epidemiology and

Biostatistics

Specialty Certification:2008 American Board of Internal Medicine2011 Gastroenterology, American Board of Internal Medicine

David Seth Goldberg, MD, MSCEPage ,

Licensure:2006 New York State Educational Department2009 Pennsylvania State Board of Medicine

Awards, Honors and Membership in Honorary Societies:2003 Outstanding Service to the First Year Class, Mount Sinai

School of Medicine2004 Lambda Chapter of Alpha Omega Alpha (AOA), Mount Sinai

School of Medicine2004 Arnold P. Gold Humanism in Medicine Honors Society, Mount

Sinai School of Medicine2005 Barry Coller Award for Excellence in Clinical Medicine,

Mount Sinai School of Medicine2006 Department of Medicine House Staff Award, Intern Teaching

Award, New York Presbyterian Hospital-Columbia University Medical Center

2010 Bradley Award for Health Evaluative Research, University of Pennsylvania Department of Medicine

2011 Frank Brooks Research Award, Division of Gastroenterology, University of Pennsylvania

2011 Third Place, Komarov Competition, Gastrointestinal Research for Gastrointestinal Fellows

2011 Young Investigator's Forum Awardee, Controversies in Liver Transplantation Conference

2011 Bradley Award for Health Evaluative Research, University of Pennsylvania Department of Medicine

2012 Young Investigator Award for the ILTS 18th Annual International Congress

2012 AGA/AASLD Academic Skills Workshop2012 AASLD Advanced Transplant Hepatology Fellowship Award2012 Young Investigator's Forum Awardee, Controversies in Liver

Transplantation Conference2013 Young Investigator's Forum Awardee, Controversies in Liver

Transplantation Conference2013 Top Grade Reviewer, Annals of Internal Medicine, 2012

Memberships in Professional and Scientific Societies and Other Professional Activities:2008-Present Member, American Association for the Study of Liver Diseases2008-Present Member, American Gastroenterological Association2011-2013 AST Trainee and Young Faculty COP (TYF COP) Committee, American Society of

Transplantation2011-2013 Liver and Intestinal Community of Practice (LICOP) Committee, American Society

of Transplantation (Executive Committee Member 2012-2013)

David Seth Goldberg, MD, MSCEPage ,

2011-Present Member, American Society of Transplantation

Editorial Positions:2008-Present Journal Reviewer (ad hoc), American Journal of Gastroenterology2010-Present Journal Reviewer (ad hoc), American Journal of Transplantation2010-Present Journal Reviewer (ad hoc), Inflammatory Bowel Diseases2011-Present Journal Reviewer (ad hoc), Annals of Internal Medicine2011-Present Journal Reviewer (ad hoc), Hepatology2012-Present Journal Reviewer (ad hoc) Liver Transplantation2012-Present Journal Reviewer (ad hoc), American Journal of Medicine

Academic and Institutional Committees:2009-Present Ethics Committee Member, Hospital of the University of

Pennsylvania

Major Academic and Clinical Teaching Responsibilities:2002-2004 Anatomy Teaching Assistant, Mount Sinai School of Medicine2003-2004 Physiology Teaching Assistant, Mount Sinai School of Medicine2004-2005 Senior Anatomy Teaching Assistant, Mount Sinai School of

Medicine2007 Ethics Grand Rounds, New York Presbyterian Hospital-Columbia

University Medical Center2011-2012 Small Group Leader, GI Pathophysiology Course, University of

Pennsylvania School of Medicine2011-2012 Gastroenterology Morning Lecture Series for Medical Students and

Medical Residents2012 Grand Rounds, Division of Gastroenterology, University of

Pennsylvania. Title: "Exception Points for Patients on the Liver Transplant Waitlist: Should There Be An Exception To The Rule

2012 Resident report, expert discussant. Case of a 42 year-old man with abnormal liver function test.

2012-Present Physical Diagnosis Small Group Leader for First Year Medical Students

2013-Present Fourth Year Medical Student Ethics Small Group Leader2014 Internal Medicine Outpatient Resident Subspecialty Conference2014 Resident report: Recent advances in HCV therapy2014 "Cholestatic Liver Disease: An Update," Seventh Annual Penn Live:

GI Endoscopy and Liver Disease 2014, Philadelphia, PA2014-Present GI Fellows Lecture Series: Liver transplant organ allocation

Lectures by Invitation (Last 5 years):Oct, 2013 "Liver Transplantation and Allocation for Hepatopulmonary

Syndrome," University of Toronto Transplant Institute; Toronto, Ontario

David Seth Goldberg, MD, MSCEPage ,

May, 2014 "Liver Transplantation in the VA Health System: Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival," Yale University Division of Transplant Surgery' New Haven, CT

Bibliography:Research Publications, peer reviewed (print or other media):

1. Goldberg D, Kryszak D, Fasano A, Green PH: Screening for Celiac Disease in Family Members: Is Follow-Up Testing Necessary? Digestive Diseases and Sciences 52(4): 1082-6, April 2007.

2. Goldberg D, French B, Thomasson A, Reddy KR, Halpern SD: Current Trends in Living Donor Liver Transplantation for Primary Sclerosing Cholangitis. Transplantation 91(10): 1148-52, May 2011.

3. Goldberg D, French B, Thomasson A, Reddy KR, Halpern SD: Waitlist Survival of Patients With Primary Sclerosing Cholangitis in the MELD Era. Liver Transplantation 17(11): 1355-63, Nov 2011.

4. Goldberg D, French B, Abt P, Feng S, Cameron AM: Increasing Disparity in Waitlist Mortality Rates with Increased MELD Scores for Candidates with Versus Without Hepatocellular Carcinoma. Liver Transplantation 18(4): 434-443, April 2012.

5. Goldberg D, Bittermann T, Makar G: Lack of Standardization in Exception Points for Patients with Primary Sclerosing Cholangitis and Bacterial Cholangitis. American Journal of Transplantation 12(6): 1603-9, June 2012.

6. Goldberg D, Lewis JD, Halpern SD, Weiner M, Lo Re III V: Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database. Pharmacoepidemiology and Drug Safety 21(7): 765-769, July 2012.

7. Bittermann T, Makar G, Goldberg D: Exception point applications for 15 points: An unintended consequence of the Share 15 policy. Liver Transplantation 18(11): 1302-1309, November 2012.

8. Ruebner R, Goldberg D*, Apt PL, Bahirwani R, Levine M, Sawinski D, Shults J, Bloom RD, Reese PP. *co-first author: Risk of End-Stage Renal Disease Among Liver Transplant Recipients with Pre-Transplant Renal Dysfunction. American Journal of Transplantation 12(11): 2958-65, November 2012.

9. Goldberg D, Lewis JD, Halpern SD, Weiner MG, Lo Re III V: Validation of a coding algorithm to identify patients with hepatocellular carcinoma in an administrative database. Pharmacoepidemiology and Drug Safety 22(1): 103-7, January 2013.

David Seth Goldberg, MD, MSCEPage ,

10. Goldberg D, Halpern SD, Reese PP: Decreased organ donation consent rates among racial and ethnic minorities and older potential donors. Critical Care Medicine 41(2): 496-505, February 2013 Notes: Epub.

11. Goldberg D, Camp A, Martinez-Camacho A, Forman L, Fortune B, Reddy KR: Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis. Liver Transplantation 19(3): 250-258, March 2013.

12. Vincent Lo Re III, Kevin Haynes, David Goldberg, Kimberly A. Forde, Dena M. Carbonari, Kimberly B. F. Leidl , Sean Hennessy, K. Rajender Reddy , Pamala A. Pawloski, Gregory W. Daniel, T. Craig Cheetham, Aarthi Iyer, Kara O. Coughlin, Sengwee Toh, Denise M. Boudreau, Nandini Selvam, William O. Cooper, Mano S. Selvan, Jeffrey J. VanWormer, Mark I. Avigan, Monika Houstoun, Gwen L. Zornberg, Judith A. Racoosin, Azadeh Shoaibi: Validity of Diagnostic Codes to Identify Cases of Severe Acute Liver Injury in the U.S. Food and Drug Administration's Mini-Sentinel Distributed Database. Pharmacoepidemiology and Drug Safety 22(1): 103-7, June 2013.

13. Goldberg DS, French BC, Trotter J, Schiano T, Shetty K, Reddy KR, Halpern SD: Underreporting of liver transplant waitlist removal due to death or clinical deterioration: Results at 4 major centers. Transplantation 96(2): 211-6, July 2013.

14. Goldberg DS, Makar G, Bittermann T, French B: Center variation in the use of non-standardized MELD exception points. Liver Transplantation 19(12): 1330-42, December 2013.

15. Bittermann T, Niu B, Hoteit M, Goldberg D: Waitlist priority for hepatocellular carcinoma beyond Milan Criteria: a potentially appropriate decision without a structured approach. American Journal of Transplantation 14(1): 79-87, January 2014.

16. Bahirwani R, Forde KA, Mu Y, Lin F, Reese P, Goldberg D, Abt P, Reddy KR, Levine M.: End-stage renal disease after liver transplantation in patients with pre-transplant chronic kidney disease. Clinical Transplantation 28(2): 205-10, February 2014.

17. Goldberg D, French B, Forde KA, Groeneveld P, Bittermann T, Backus L, Halpern SD, Kaplan D: Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival. JAMA 311(12): 1234-1243, March 2014.

18. Goldberg D, Abt PL: Improving outcomes in DCDD liver transplantation: There can only be strength in numbers. American Journal of Transplantation 14(5): 1016-1020, May 2014.

David Seth Goldberg, MD, MSCEPage ,

19. Goldberg D, Krok K, Batra S, Trotter J, Kawut S, Fallon M: Analysis of National Data on Liver Transplantation and Organ Allocation for Patients with Hepatopulmonary Syndrome. Gastroenterology 146(5): 1256-1265, May 2014.

20. Bittermann T, Hoteit M, Abt P, Forde K, Goldberg D: Waiting time and explant pathology in transplant recipients with hepatocellular carcinoma: a novel study using national data. American Journal of Transplantation 14(7): 1657-63, July 2014.

21. Sulewski ME, Wolf JH, Hasz R, West S, Goldberg D, Krok KL, Olthoff KM, Shaked A, Levine MH, Abt PL: Combined heart-liver transplantation; implications for liver-alone wait list mortality. Transplantation 98(5): 45-7, September 2014.

22. Goldberg D, Batra S, Sahay S, Kawut S, Fallon MB: MELD Exceptions for Portopulmonary Hypertension: Current Policy and Future Implementation American Journal of Transplantation 14(9): 2081-7, September 2014.

23. Goldberg D, French B, Abt P, Olthoff K, Shaked A: Superior Survival Using Living Donors and Donor-Recipient Matching Using a Novel Living Donor Risk Index. Hepatology 60(5): 1717-26, November 2014.

24. Goldberg D, Reese P, Amaral S, Abt P: Reframing the impact of combined heart-liver allocation on liver transplant waitlist candidates. Liver Transplantation 20(11): 1356-64, November 2014.

25. Niu B, Forde K, Goldberg D: Coding algorithms for identifying patients with cirrhosis and hepatitis B or C virus using administrative data Pharmacoepidemiology and Drug Safety 2014. In press.

26. Scott FI, Vajravelu RK, Bewtra M, Mamtani R, Lee D, Goldberg DS, Lewis JD. The Benefit-to-Risk Balance of Combining Infliximab With Azathioprine Varies With Age: A Markov Model. 2014; In Press.

Research Publications, non-peer reviewed:1. David E. Kaplan, David S. Goldberg: Liver Transplants Among US Veterans­Reply.

JAMA 312(4): 437, July 2014.

Abstracts (Last 3 years):1. Goldberg D, French B, Thomasson A, Reddy KR, Halpern SD: Waitlist Survival of

Patients with Primary Sclerosing Cholangitis in the Post-MELD Era. Young Investigators ' Forum 2011, Breckenridge, CO February 2011 Notes: Oral.

2. Goldberg D, French B, Thomasson A, Reddy KR, Halpern SD: Current Trends in Living Donor Liver Transplantation for Primary Sclerosing Cholangitis. American Transplant Congress June 2011 Notes: Poster.

David Seth Goldberg, MD, MSCEPage ,

3. Goldberg D, French B, Thomasson A, Reddy KR, Halpern SD: Waitlist Survival of Patients with Primary Sclerosing Cholangitis in the Post-MELD Era. American Transplant Congress June 2011 Notes: Poster.

4. Gupta M, Porrett P, Goldberg D, Abt PL, Levine MH: Significantly poorer survival of liver transplant recipients with hepatocellular carcinoma (HCC) and high true MELD. Academic Surgical Congress February 2012 Notes: Oral.

5. Goldberg D, French B, Abt P, Feng S, Cameron A: Increasing Disparity in Waitlist Mortality Rates with Increased MELD Scores for Candidates with Versus Without Hepatocellular Carcinoma. International Liver Transplant Congress June 2012 Notes: Oral.

6. Goldberg D, Reddy KR: Risk of Waitlist Mortality for Candidates with Primary Sclerosing Cholangitis and Episodes of Bacterial Cholangitis. American Transplant Congress June 2012 Notes: Poster.

7. Goldberg D, Ruebner R, Abt PL, Bahirwani R, Levine M, Sawinski D, SHults J, Bloom RD, Reese PP: Risk of end-stage renal disease among liver transplant recipients with pre-transplant chronic kidney disease. American Transplant Congress June 2012 Notes: Poster.

8. Lo Re V 3rd, Haynes K, Fortier K, Carbonari DM, Lewis JD, Strom BL, Forde KA, Goldberg D, Reddy KR, Roy J, Marks AR, De Boer J, Corley DA: Validity of Diagnostic Codes and Liver-Related Laboratory Abnormalities to Identify Acute Liver Failure among Kaiser Permanente Patients with Diagnoses of Drug-Induced Hepatitis. 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management,August 2012 Notes: Oral.

9. Bittermann T, Makar G, Goldberg D. : Exception point applications for 15 points: An unintended consequence of the Share 15 policy. AASLD Liver Meeting, November 2012 Notes: Oral.

10. Goldberg D, Halpern SD, Reese PP: Decreased organ donation consent rates among racial and ethnic minorities and older potential donors. AASLD Liver Meeting November 2012 Notes: Oral.

11. Bittermann T, Hoteit M, Niu B, Goldberg D: Waitlist priority for hepatocellular carcinoma beyond Milan Criteria: a potentially appropriate decision without a structured approach. AASLD Liver Meeting, November 2013 Notes: Poster.

12. Goldberg D, Krok K, Batra S, Kawut S, Fallon M: Liver Transplantation for Hepatopulmonary Syndrome: Does Oxygenation Matter. AASLD Liver Meeting November 2013 Notes: Oral.

David Seth Goldberg, MD, MSCEPage ,

13. Goldberg DS, Makar G, Bittermann T, French B: Center variation in the use of non-standardized MELD exception points. AASLD Liver Meeting November 2013 Notes: Poster.

14. Goldberg D, Batra S, Sahay S, Kawut S, Fallon M: Liver Transplantation Outcomes for Portopulmonary Hypertension in the United States: 2006-2013. European Association for the Study of Liver Diseases (EASL) International Liver Congress April 2014 Notes: Poster presentation.

Editorials, Reviews, Chapters, including participation in committee reports (print or other media):

1. Goldberg D, Weisberg I, Diuguid D, Gaglio P, Alobeid B, Fink S, Radhakrishnan J: Worth a Second Look. The American Journal of Medicine 122(1): 24-26, January 2009.

2. Goldberg D, Ahmad N: Intramural Dissection of the Esophagus in a Young Man Presenting with Hematemesis. Clinical Gastroenterology and Hepatology 8(4): A18, April 2010.

3. Goldberg DS, Fallon MB: Model for End-Stage Liver Disease­Based Organ Allocation: Managing the Exceptions to the Rules. Clinical Gastroenterology and Hepatology 11(5): 452-3, May 2013.

4. Bittermann T, Goldberg D: CMV and Post-Transplant Biliary Complications: Elusive Offender or Innocent Bystander? Liver Transplantation 19(10): 1062-4, October 2013.

5. Goldberg D, Fallon M: Hepatopulmonary Syndrome. Complications of Cirrhosis: Evaluation and Management. Springer, 2014. In Press.

6. Goldberg D, Olthoff K: Standardizing MELD Exceptions: Current Challenges and Future Directions. Current Transplantation Reports 1(4), December 2014. In Press.

Alternative Media:1. David Goldberg: Exception points for waitlisted liver transplant candidates with HCC:

Do we need to reform the current allocation policy. Consumer Talk with Marion Joyce. AM 1490 WGCH. 2012.

2. Andrew Seaman: Liver transplant chances tied to distance from center. Reuters Health March 2014.

3. Andrew Seaman: Liver transplant chances tied to distance from center. Chicago Tribune March 2014.

David Seth Goldberg, MD, MSCEPage ,

4. Marie McCullough: Check Up: Centralizing special care limits access. Philadelphia Inquirer March 2014.

5. Robert Preidt: Distance From VA Liver Transplant Center May Affect Vets' Survival. US News and Health Report HealthDay March 2014.

6. Pauline Chen: Where You Live Matters for Lifesaving Liver Transplants. New York Times May 2014.

7. Leeann Donegan: Penn Medicine Study: Liver Transplant Patients Who Receive Organs from Living Donors More Likely to Survive than Those Who Receive Organs from Deceased Donors. Penn Medicine in the News July 2014.

8. Leeann Donegan: Some Patients Receive Unnecessary Prioritization for Liver Transplantation, Penn Medicine Study Finds. Penn Medicine in the News July 2014.

9. Stacey Kusterbeck: Organ donation consent rates lower among racial and ethnic minorities. Medical Ethics Advisor July 2014.

10. Goldberg D: Waiting for Liver Transplantation. WHYY-FM Newsworks Tonight with Taunya English 2014.

11. Goldberg D, Wood L, Olthoff K: Living Liver Donor Program. 6ABC News Webchat 2014.

October 30, 2014

American Society of Transplantation1120 Route 73, Suite 200Mount Laurel, NJ 08054

Dear AST Board of Directors:

                      It is with great enthusiasm that I nominate David S. Goldberg, M.D., M.S.C.E., on behalf of the Liver Intestine Community of Practice (LICOP), for the 2015 AST Clinical Science Career Development Award.  Dr. Goldberg is a rising star in the arena of liver transplantation and hepatology. At this early stage in his career, Dr. Goldberg already has a broad spectrum of areas of investigation and associated grant award and publication success. Most recently, he has developed strategies aimed at reorganizing and improving liver allocation and associated policy development.  He has been instrumental in illuminating to UNOS and the liver transplant arena at­large the significant disparities in access to care and liver transplant wait listing variability that translates into MELD score differences across the UNOS regions. I cannot emphasize enough, the importance of his novel and very thoughtful work in changing the face of liver transplantation based on his initiatives. He is a highly motivated, astute, and innovative investigator, and will prove to be a ‘game changer’ in the field of liver transplantation.   Accordingly, Dr. Goldberg has been awarded a NIH K08 grant looking at organ allocation on a broader scale and I am confident that his work stemming from this award will have a major impact on issues of disparities in liver transplantation.  He has great promise to become a national and international leader in liver disease and transplantation, and the AST Clinical Science Career Development Award will help to realize and to recognize his potential.

By way of introduction, Dr. Goldberg received a BA in Judaic Studies from Brown University, Providence, RI in 2001, and his medical degree from the Mount Sinai School of Medicine, New York, NY in 2005.  He then completed his internship and residency training in Internal Medicine at the New York Presbyterian Hospital­Columbia University Medical Center in 2008. Successive fellowships in Gastroenterology (2008­2011) and Transplant Hepatology (2012­2013) followed thereafter at the Hospital of the University of Pennsylvania.  Additionally, Dr. Goldberg received his Masters of Science in Clinical Epidemiology from the University of Pennsylvania, Philadelphia, PA in 2011.

Dr. Goldberg is currently an Instructor in Medicine at the University of Pennsylvania Perelman School of Medicine, and is on the springboard for promotion to Assistant Professor this year.  He was recently appointed Medical Director for Living Donor Liver Transplantation at the Hospital of the University of Pennsylvania in 2013.  Dr. Goldberg’s combined academic gifts and zeal for continually broadening and sharing his knowledge base are clearly in evidence with the following appointments at the University of 

Pennsylvania:  Faculty Fellow, Clinical Center for Epidemiology and Biostatistics (2011­present); Investigator­in­Training, Center for Pharmacoepidemiology Research and Training (2012­present); and LDI Fellow, Leonard Davis Institute (2013­present).

As so outlined on his CV, it is worth noting that during the ten year period spanning the years 2003­2013, Dr. Goldberg received some 16 honors and awards for outstanding service and/or achievement in areas as diverse as investigative research, health evaluative research, academic achievement, teaching, excellence in clinical medicine, and outstanding service to the First Year Class at the Mount Sinai School of Medicine.  As with his broad training and experience thus far, such diverse recognition is, I believe, a testament to Dr. Goldberg’s comprehensive and compassionate approach to the field of medicine.

Even at this early stage in his medical career, Dr. Goldberg has made formidable contributions to research­science with 21 peer­reviewed articles published in respected scientific journals within his field, 14 of which he has served as the senior author.  An additional four peer­reviewed articles are currently in press, three of which he has served as the senior author.  In the last three years, Dr. Goldberg has presented 14 abstracts of his research at esteemed scientific meetings within his field.  Dr. Goldberg has served as the senior author for an additional five of six book chapters, editorials or reviews, the final two of which are currently in press.  Finally, as documented on his CV, Dr. Goldberg’s research has reached a much broader audience in recent months through alternative media sources such as talk radio and the popular press.  

Dr. Goldberg is currently an ad hoc Journal Reviewer for such esteemed publications as the American Journal of Gastroenterology, the American Journal of Transplantation, Inflammatory Bowel Diseases, Annals of Internal Medicine, Hepatology, Liver Transplantation, and the American Journal of Medicine.  He currently holds active membership in the American Association for the Study of Liver Diseases, the American Gastroenterological Association and, of course, the American Society of Transplantation. Dr. Goldberg has been very active in the AST and has served on the AST Trainee and Young Faculty COP Committee (2011­2013) and the Liver and Intestinal Community of Practice (LICOP) Executive Committee (2011­2013).  At the institutional level, Dr. Goldberg has been an active member of the Ethics Committee at the Hospital of the University of Pennsylvania since 2009.  

   In summary, the AST career development award would be well deserved by Dr Goldberg and would facilitate recognition of his outstanding research and contributions to the field of liver transplantation.  This award will also help to develop future policies and strategies aimed at improving disparities in access to care and in wait listing transplant candidates. Dr Goldberg had been a true asset to the AST and I am confident that he will continue to make major contributions to the society and to our field.   If I can be of any further assistance in the support of Dr. Goldberg’s candidacy for the AST Clinical Science Career Development Award, please feel free to contact me.

Sincerely yours,

Susan L. Orloff, M.D., F.A.C.S.

Liver and Intestinal Community of Practice, Past ChairProfessor of SurgeryChief, Division of Abdominal Organ Transplantation/Hepatobiliary SurgeryAdjunct Professor, Department of Microbiology & ImmunologyOregon Health & Science UniversityChief, Portland VA Medical Center Transplant Program3181 S.W. Sam Jackson Park Road Portland, OR 97239 MC: L590

David P. Foley, MD, FACS Jacqueline G. O’Leary, MD MPHChair  Co­ChairLiver and Intestinal Community of Practice Liver and Intestinal Community of Practice

Josh Levitsky, MD, MS Jennifer Lai, MD, MBABoard Liaison Member­at­LargeLiver and Intestinal Community of Practice Liver and Intestinal Community of Practice

Paul Martin, MD Timothy M. Schmitt, MD, FACSMember­at­Large Member­at­LargeLiver and Intestinal Community of Practice Liver and Intestinal Community of Practice

Lisa VanWagner, MD, MSCIMember­at­LargeLiver and Intestinal Community of Practice